KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) EPS (Basic) (2019 - 2025)

Clover Health Investments' EPS (Basic) history spans 7 years, with the latest figure at -$0.1 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 150.0% year-over-year to -$0.1; the TTM value through Dec 2025 reached -$0.17, down 70.0%, while the annual FY2025 figure was -$0.17, 88.89% down from the prior year.
  • EPS (Basic) reached -$0.1 in Q4 2025 per CLOV's latest filing, down from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.01 in Q4 2022 to a low of -$0.78 in Q2 2021.
  • Average EPS (Basic) over 5 years is -$0.14, with a median of -$0.08 recorded in 2021.
  • Peak YoY movement for EPS (Basic): crashed 4000.0% in 2021, then surged 116.67% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.44 in 2021, then skyrocketed by 102.27% to $0.01 in 2022, then crashed by 1500.0% to -$0.14 in 2023, then surged by 71.43% to -$0.04 in 2024, then tumbled by 150.0% to -$0.1 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's EPS (Basic) are -$0.1 (Q4 2025), -$0.05 (Q3 2025), and -$0.02 (Q2 2025).